• OPEN AN ACCOUNT
Indian Indices
Nifty
25,839.65 -120.90
(-0.47%)
Sensex
84,613.21 -53.07
( -0.06%)
Bank Nifty
59,222.35 -16.20
( -0.03%)
Nifty IT
38,130.60 -460.10
( -1.19%)
Global Indices
Nasdaq
47,580.49 -179.84
(-0.38%)
Dow Jones
6,861.32 -6.19
(-0.09%)
Hang Seng
50,689.00 107.06
(0.21%)
Nikkei 225
9,640.52 -4.57
(-0.05%)
Forex
USD-INR
90.09 0.19
(0.21%)
EUR-INR
104.90 0.24
(0.23%)
GBP-INR
120.04 0.25
(0.21%)
JPY-INR
0.58 0.00
(0.12%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Board of Sanofi India approves change in directorate
Oct 27,2025
The Board of Sanofi India at its meeting held on 27 October 2025 has approved the following-

Appointment of Deepak Arora (DIN: 07495638) as an Additional Director of the Company with effect from 27 October 2025 and as a Managing Director (Key Managerial Personnel) of the Company for a term of 3 (three) years effective from 27 October 2025.

Stepping down of Rachid Ayari as Interim Managing Director of the Company with effect from close of 26 October 2025. However, Rachid Ayari would continue to serve the Company in his role as Whole time Director and Chief Financial Officer of the Company.